Legislation


HB 4472 – Michigan

Status: Enacted
Year Introduced: 2017
Year Enacted: 2018
Link: http://www.legislature.mi.gov/(S(r1h5ctpzhpcewmfio14zlbab))/mileg.aspx?page=GetObject&objectname=2017-HB-4472

TO ALLOW PHARMACISTS TO DISPENSE FDA-DESIGNATED INTERCHANGEABLE BIOLOGICAL DRUG PRODUCTS: When a pharmacist receives a prescription for a brand name drug product or biological drug product, the pharmacist may dispense a lower cost but not higher cost generically equivalent drug product or interchangeable biological drug product if available in the pharmacy.  When a purchaser requests a lower cost generically equivalent drug product or interchangeable biological drug product, the pharmacist shall dispense a lower cost but not higher cost generically equivalent drug product or interchangeable biological drug product if available in the pharmacy. If a drug or biological drug product is dispensed that is not the prescribed brand, the pharmacist must notify the purchaser and the prescription label must indicate both the name of the brand prescribed and the name of the brand dispensed.


Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found

Leave A Comment